does hims sell tirzepatide & Hers Begins Selling Zepbound Hims' obesity drug business may

Hims & Hers' stock plummeted

Plan sponsor implications Alberta Blue Cross frames the 2026 pipeline report as a tool to help plan sponsors anticipate new cost drivers and high-impact therapies, supporting what it calls informed decision making on proactive benefit management strategies to balance patient access with sustainable plan design [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]

For those who eventually taper off the drugs, gyms could fill the gap with programs built around check-ins, maintenance and support to help sustain weight loss.

This would benefit pets with Inflammatory bowel disease, environmental allergies, food allergies, chronic diarrhea, chronic vomiting, and other signs of GI upset or poor function